|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$679,649
|
$271,860
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$79,544
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
$840
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
$2,065
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
$2,578
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-05
|
$620,114
|
$620,114
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Mechanism of non-oncogene addiction
|
1R01CA211594-01A1
|
$363,713
|
$363,713
|
AZAM, MOHAMMAD
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$91,803
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$5,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$2,725
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$1,514
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$635
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
|
5K22CA190674-04
|
$161,692
|
$80,846
|
BARTH, BRIAN
|
UNIVERSITY OF NEW HAMPSHIRE
|
|
Cancer Center Support Grant
|
3P30CA042014-29S1
|
$125,000
|
$3,750
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S2
|
$250,000
|
$7,500
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S3
|
$248,625
|
$7,459
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S4
|
$114,251
|
$3,428
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S5
|
$59,693
|
$1,791
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S6
|
$155,422
|
$4,663
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia
|
4UH3CA213385-03
|
$87,498
|
$87,498
|
CHEN, WENYONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Characterization of CD99 as a Therapeutic Target in the Myelodysplastic Syndromes and Acute Myeloid Leukemia
|
5K08CA194275-02
|
$177,336
|
$177,336
|
CHUNG, STEPHEN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Genetic Analysis of Myeloproliferative Disease
|
5R01CA076167-15
|
$307,800
|
$307,800
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
5R01CA101774-16
|
$337,725
|
$337,725
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Integrated Training in Cancer Model Systems
|
5T32CA009156-43
|
$793,807
|
$158,761
|
DER, CHANNING
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-20S1
|
$225,000
|
$9,000
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-20S2
|
$248,465
|
$9,939
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-20S3
|
$124,966
|
$4,999
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
5P30CA069533-20
|
$2,310,000
|
$92,400
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Characterizing the landscape of resistance and persistence mechanisms in CML
|
5R01CA065823-22
|
$329,175
|
$329,175
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-17S1
|
$240,897
|
$4,818
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-17S2
|
$254,917
|
$5,098
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-17S3
|
$199,999
|
$4,000
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-17S4
|
$124,730
|
$2,495
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA091842-17
|
$4,207,812
|
$84,156
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
SPORE in Myeloid Malignancies
|
5P50CA206963-02
|
$2,300,000
|
$276,000
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
G0S2 in Chronic Myeloid Leukemia Disease Progression and Imatinib Resistance
|
1K22CA216008-01
|
$193,030
|
$193,030
|
EIRING, ANNA
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
|
City of Hope Lymphoma SPORE
|
2P50CA107399-11A1
|
$2,500,000
|
$900,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
2P30CA016359-39
|
$4,530,485
|
$45,305
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016359-39S1
|
$250,000
|
$2,500
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016359-39S2
|
$60,000
|
$600
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016359-39S3
|
$56,337
|
$563
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016359-39S4
|
$250,000
|
$2,500
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Core Support for Cancer Center
|
3P30CA013330-45S1
|
$3,646,138
|
$109,384
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Sphingolipids in Cancer Biology and Therapy
|
5P01CA097132-15
|
$1,298,387
|
$181,774
|
HANNUN, YUSUF
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
MPN Research Consortium
|
2P01CA108671-10A1
|
$3,937,342
|
$3,701,101
|
HOFFMAN, RONALD
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies
|
1R01CA232845-01
|
$630,136
|
$630,136
|
IZUMIYA, YOSHIHIRO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Highly Sensitive Chimerism Testing to Detect Early Leukemia Relapse Post-Allo-Transplantation
|
1R41CA232805-01
|
$173,566
|
$86,783
|
KANAAN, SAMI
|
CHIMEROCYTE, INC.
|
|
Molecular-Cellular Regulation of Hematopoietic Stem Cells
|
ZIA BC 010001
|
$776,575
|
$194,144
|
Keller, Jonathan
|
CCR (NCI)
|
|
Cancer Center Support Grant P30
|
3P30CA093373-16S1
|
$250,000
|
$7,500
|
LARA, PRIMO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant P30
|
3P30CA093373-16S2
|
$89,478
|
$2,684
|
LARA, PRIMO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $19,494,791
|